We also discovered that up to 48% of patients in Beltran Prostate cohort (composed of NEPC and castration resistant PCa) harbor BTF3 overexpression or amplification according to the cBioPortal database (Fig. 6g). This evidence concerns the gene BTF3 and posterior cortical atrophy.